The use of objective adherence measures targeting four placebo microbicide delivery forms in the Quatro Clinical Crossover Study-Reference-Cited by-同舟云学术

The use of objective adherence measures targeting four placebo microbicide delivery forms in the Quatro Clinical Crossover Study

Published:2021-10 Issue:1 Volume:1 Page:
ISSN:2768-0622
Container-title:Clinical and Translational Discovery
language:en
Short-container-title:Clinical and Translational Dis

Author:

Jacot Terry A.¹^ORCID,Adedipe Oluwatosin E.¹,Godbout Susan¹,Peele Abby G.¹,Schwartz Jill L.¹,Ju Susan¹,Cunningham Tina D.²,Montgomery Elizabeth³,Straten Ariane³,Beksinska Mags⁴,Smit Jenni⁴,Mgodi Nyaradzo⁵,Thurman Andrea R.¹,Clark Meredith R.¹,Doncel Gustavo F.¹

Affiliation:

1. CONRAD/Department of Obstetrics and Gynecology Eastern Virginia Medical School Norfolk and Arlington Virginia

2. School of Health Professions Eastern Virginia Medical School Norfolk Virginia

3. Women's Global Health Imperative, RTI International San Francisco California

4. MRU (MatCH Research Unit) Department of Obstetrics and Gynaecology Faculty of Health Sciences University of the Witwatersrand Durban South Africa

5. University of Zimbabwe Clinical Trials Research Centre Harare Zimbabwe

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctd2.13

Reference37 articles.

1. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

2. Study Product Adherence Measurement in the iPrEx Placebo-Controlled Trial

3. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

4. Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring

5. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women